Ann: RELINT: FPH: Disclosure of Director's and Officers' Relevant Interests

• Release Date: 01/12/14 16:22
• Summary: RELINT: FPH: Disclosure of Director's and Officers' Relevant Interests
• Price Sensitive: No
• Download Document  4.31KB

					FPH
01/12/2014 16:22
RELINT
NOT PRICE SENSITIVE
REL: 1622 HRS Fisher & Paykel Healthcare Corporation Limited

RELINT: FPH: Disclosure of Director's and Officers' Relevant Interests

Name of director or officer of public issuer:  Paul Nigel SHEARER
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Senior VP Sales & Marketing

B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities:   Ordinary shares and options to
acquire ordinary shares

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Beneficial Ownership
Name of registered holder of securities   Paul Nigel SHEARER

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 24 November 2014
Consideration paid for acquisition:    $Nil

If the relevant interest was disposed of--
Date of cancellation: 24 November 2014
Consideration received for cancellation:   $Nil

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acqusition or disposal took place:  Cancellation of 60,000 FPH options
and issue of 23,226 ordinary shares

E Total number of transactions this notice relates to:  One

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   3 September 2014

Name of director or officer of public issuer:  Lewis George GRADON
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Senior VP Products & Technology

B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities:   "(i) Ordinary shares and options to
acquire ordinary shares;
(ii) Ordinary shares"

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Beneficial Ownership
Name of registered holder of securities   Lewis George GRADON

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition:   24 November 2014
Consideration paid for acquisition:   $Nil

If the relevant interest was disposed of--
Date of cancellation and sale:  "(i) 24 November 2014;
(ii) 25 November 2014"
Consideration received for cancellation and sale:   (i) $Nil;  (ii) $42,978

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acqusition or disposal took place:  "(i) Cancellation of 60,000 FPH
options and
 issue of 23,226 ordinary shares;
(ii) Sale of 7,800 Ordinary shares"

E Total number of transactions this notice relates to:  Two

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   3 September 2014

Name of director or officer of public issuer:  Michael Grenfell DANIELL
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Managing Director/Chief Executive Officer

B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities:   Ordinary shares and options to
acquire ordinary shares

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Beneficial Ownership
Name of registered holder of securities   Michael Grenfell DANIELL

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition   24 November 2014
Consideration paid for acquisition   $Nil

If the relevant interest was disposed of--
Date of cancellation: 24 November 2014
Consideration received for cancellation:   $Nil

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acqusition or disposal took place:  Cancellation of 100,000 FPH options
and issue of 43,340 ordinary shares

E Total number of transactions this notice relates to:  One

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   3 September 2014
End CA:00258347 For:FPH    Type:RELINT     Time:2014-12-01 16:22:16